These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
20-3672603
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
12300 Grant Street, Thornton, CO
|
|
80241
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|
Common
|
ASTI
|
OTC
|
|
Large accelerated filer
|
|
o
|
|
Accelerated filer
|
|
o
|
|
Non-accelerated filer
|
|
x
|
|
Smaller reporting company
|
|
x
|
|
|
|
|
|
Emerging growth company
|
|
o
|
|
|
|
|
|
|
||
|
Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
||
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
•
|
Our limited operating history and lack of profitability;
|
|
•
|
Our ability to develop demand for, and sales of, our products;
|
|
•
|
Our ability to attract and retain qualified personnel to implement our business plan and corporate growth strategies;
|
|
•
|
Our ability to develop sales, marketing and distribution capabilities;
|
|
•
|
Our ability to successfully develop and maintain strategic relationships with key partners, including OEMs, system integrators, distributors, retailers and e-commerce companies, who deal directly with end users in our target markets;
|
|
•
|
The accuracy of our estimates and projections;
|
|
•
|
Our ability to secure additional financing to fund our short-term and long-term financial needs;
|
|
•
|
Our ability to maintain the listing of our common stock on the OTCBB Market;
|
|
•
|
The commencement, or outcome, of legal proceedings against us, or by us, including ongoing ligation proceedings;
|
|
•
|
Changes in our business plan or corporate strategies;
|
|
•
|
The extent to which we are able to manage the growth of our operations effectively, both domestically and abroad, whether directly owned or indirectly through licenses;
|
|
•
|
The supply, availability and price of equipment, components and raw materials, including the elements needed to produce our photovoltaic modules;
|
|
•
|
Our ability to expand and protect the intellectual property portfolio that relates to our consumer electronics, photovoltaic modules and processes;
|
|
•
|
Our ability to implement remediation measures to address material weaknesses in internal control;
|
|
•
|
General economic and business conditions, and in particular, conditions specific to consumer electronics and the solar power industry; and
|
|
•
|
Other risks and uncertainties discussed in greater detail in the section captioned "Risk Factors."
|
|
|
|
September 30,
2019 |
|
December 31,
2018 |
||||
|
ASSETS (substantially pledged)
|
|
|
|
|
||||
|
Current Assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
24,505
|
|
|
$
|
18,159
|
|
|
Trade receivables, net of allowance of $45,362 and $45,644, respectively
|
|
22,403
|
|
|
165,160
|
|
||
|
Inventories, net
|
|
684,390
|
|
|
660,791
|
|
||
|
Prepaid expenses and other current assets
|
|
164,325
|
|
|
138,369
|
|
||
|
Total current assets
|
|
895,623
|
|
|
982,479
|
|
||
|
Property, Plant and Equipment:
|
|
32,911,969
|
|
|
36,621,187
|
|
||
|
Less accumulated depreciation and amortization
|
|
(28,632,301
|
)
|
|
(32,207,829
|
)
|
||
|
|
|
4,279,668
|
|
|
4,413,358
|
|
||
|
Other Assets:
|
|
|
|
|
||||
|
Patents, net of accumulated amortization of $408,612 and $363,533, respectively
|
|
826,711
|
|
|
862,429
|
|
||
|
Other non-current assets
|
|
—
|
|
|
34,061
|
|
||
|
|
|
826,711
|
|
|
896,490
|
|
||
|
Total Assets
|
|
$
|
6,002,002
|
|
|
$
|
6,292,327
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
|
|
|
|
||||
|
Current Liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
1,457,378
|
|
|
$
|
2,318,655
|
|
|
Related party payables
|
|
460,000
|
|
|
270,740
|
|
||
|
Accrued expenses
|
|
1,510,558
|
|
|
1,562,435
|
|
||
|
Accrued interest
|
|
1,775,647
|
|
|
1,198,279
|
|
||
|
Notes payable
|
|
1,506,530
|
|
|
1,516,530
|
|
||
|
Current portion of long-term debt
|
|
—
|
|
|
349,093
|
|
||
|
Mortgage
|
|
5,917,315
|
|
|
—
|
|
||
|
Secured promissory notes, net of discount of $1,341,915 and $2,824,365, respectively
|
|
5,830,982
|
|
|
3,447,380
|
|
||
|
Promissory notes, net of discounts of $30,000 and $104,583, respectively
|
|
954,437
|
|
|
1,239,854
|
|
||
|
Convertible notes, net of discounts of $853,672 and $394,011, respectively
|
|
2,004,241
|
|
|
1,852,722
|
|
||
|
Embedded derivative liability
|
|
7,064,541
|
|
|
10,114,452
|
|
||
|
Total current liabilities
|
|
28,481,629
|
|
|
23,870,140
|
|
||
|
Long-term debt, net of current portion
|
|
—
|
|
|
5,028,969
|
|
||
|
Accrued Warranty Liability
|
|
24,861
|
|
|
29,114
|
|
||
|
Total Liabilities
|
|
28,506,490
|
|
|
28,928,223
|
|
||
|
Commitments and Contingencies
|
|
—
|
|
|
—
|
|
||
|
Stockholders’ Deficit:
|
|
|
|
|
||||
|
Series A preferred stock, $.0001 par value; 750,000 shares authorized as of September 30, 2019 and December 31, 2018; 48,100 and 60,756 shares issued and outstanding as of September 30, 2019 and December 31, 2018 ($691,571 and $822,620 Liquidation Preference, respectively)
|
|
5
|
|
|
6
|
|
||
|
Common stock, $0.0001 par value, 20,000,000,000 shares authorized as of September 30, 2019 and December 31, 2018; 2,856,539,850 and 63,537,885 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively
|
|
285,654
|
|
|
6,354
|
|
||
|
Additional paid in capital
|
|
397,674,171
|
|
|
395,889,712
|
|
||
|
Accumulated deficit
|
|
(420,464,318
|
)
|
|
(418,531,968
|
)
|
||
|
Total stockholders’ deficit
|
|
(22,504,488
|
)
|
|
(22,635,896
|
)
|
||
|
Total Liabilities and Stockholders’ Deficit
|
|
$
|
6,002,002
|
|
|
$
|
6,292,327
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
For the Three Months Ended September 30,
|
|
For the Nine Months Ended September 30,
|
|
||||||||||||||
|
|
|
2019
|
|
2018
|
|
|
2019
|
|
2018
|
|
|
||||||||
|
Revenues
|
|
$
|
338,373
|
|
|
$
|
32,001
|
|
|
|
$
|
628,124
|
|
|
$
|
512,473
|
|
|
|
|
Costs and Expenses
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cost of revenues
|
|
74,271
|
|
|
—
|
|
|
|
282,825
|
|
|
503,609
|
|
|
|
||||
|
Research, development and manufacturing operations
|
|
460,775
|
|
|
516,782
|
|
|
|
1,078,842
|
|
|
2,389,863
|
|
|
|
||||
|
Selling, general and administrative
|
|
633,566
|
|
|
607,784
|
|
|
|
1,545,852
|
|
|
2,243,925
|
|
|
|
||||
|
Depreciation and amortization
|
|
58,154
|
|
|
91,104
|
|
|
|
185,163
|
|
|
289,324
|
|
|
|
||||
|
Total Costs and Expenses
|
|
1,226,766
|
|
|
1,215,670
|
|
|
|
3,092,682
|
|
|
5,426,721
|
|
|
|
||||
|
Loss from Operations
|
|
(888,393
|
)
|
|
(1,183,669
|
)
|
|
|
(2,464,558
|
)
|
|
(4,914,248
|
)
|
|
|
||||
|
Other Income/(Expense)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other Income, net
|
|
6,000
|
|
|
13,144
|
|
|
|
842,500
|
|
|
13,144
|
|
|
|
||||
|
Interest Expense
|
|
(1,907,895
|
)
|
|
(1,730,717
|
)
|
|
|
(6,740,340
|
)
|
|
(5,279,259
|
)
|
|
|
||||
|
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net
|
|
1,510,883
|
|
|
3,284,736
|
|
|
|
6,430,048
|
|
|
2,599,870
|
|
|
|
||||
|
Total Other Income/(Expense)
|
|
(391,012
|
)
|
|
1,567,163
|
|
|
|
532,208
|
|
|
(2,666,245
|
)
|
|
|
||||
|
Net Loss
|
|
$
|
(1,279,405
|
)
|
|
$
|
383,494
|
|
|
|
$
|
(1,932,350
|
)
|
|
$
|
(7,580,493
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net Loss Per Share (Basic and Diluted)
|
|
$
|
(0.001
|
)
|
|
$
|
0.20
|
|
|
|
$
|
(0.003
|
)
|
|
$
|
(0.45
|
)
|
|
|
|
Weighted Average Common Shares Outstanding (Basic and Diluted)
|
|
1,457,404,260
|
|
|
22,739,044
|
|
|
|
705,196,069
|
|
|
16,827,420
|
|
|
|
||||
|
|
|
Common Stock
|
|
Series A Preferred Stock
|
|
Additional
Paid-In Capital |
|
Accumulated
Deficit |
|
Total
Stockholders’ Equity (Deficit) |
||||||||||||||||
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balance, June 30, 2019
|
|
696,089,337
|
|
|
$
|
69,609
|
|
|
48,100
|
|
|
$
|
5
|
|
|
$
|
397,258,622
|
|
|
$
|
(419,184,913
|
)
|
|
$
|
(21,856,677
|
)
|
|
Interest and Dividend Expense paid with Common Stock
|
|
89,313,372
|
|
|
8,932
|
|
|
—
|
|
|
—
|
|
|
7,393
|
|
|
—
|
|
|
16,325
|
|
|||||
|
Conversion of St.George Note into Common Shares
|
|
457,222,223
|
|
|
45,722
|
|
|
—
|
|
|
—
|
|
|
43,278
|
|
|
—
|
|
|
89,000
|
|
|||||
|
Conversion of BayBridge Note into Common Shares
|
|
605,769,231
|
|
|
60,577
|
|
|
—
|
|
|
—
|
|
|
25,423
|
|
|
—
|
|
|
86,000
|
|
|||||
|
Conversion of Bellridge Note into Common Shares
|
|
474,484,128
|
|
|
47,448
|
|
|
—
|
|
|
—
|
|
|
41,552
|
|
|
—
|
|
|
89,000
|
|
|||||
|
Conversion of Power Up Note into Common Shares
|
|
155,824,176
|
|
|
15,582
|
|
|
—
|
|
|
—
|
|
|
(982
|
)
|
|
—
|
|
|
14,600
|
|
|||||
|
Conversion of GS Capital Note into Common Shares
|
|
311,168,154
|
|
|
31,117
|
|
|
—
|
|
|
—
|
|
|
26,601
|
|
|
—
|
|
|
57,718
|
|
|||||
|
Stock issued for fees
|
|
66,669,229
|
|
|
6,667
|
|
|
—
|
|
|
—
|
|
|
1,098
|
|
|
—
|
|
|
7,765
|
|
|||||
|
Loss on Extinguishment of Liabilities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
271,186
|
|
|
—
|
|
|
271,186
|
|
|||||
|
Net Loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,279,405
|
)
|
|
(1,279,405
|
)
|
|||||
|
Balance at September 30, 2019
|
|
2,856,539,850
|
|
|
$
|
285,654
|
|
|
48,100
|
|
|
$
|
5
|
|
|
$
|
397,674,171
|
|
|
$
|
(420,464,318
|
)
|
|
$
|
(22,504,488
|
)
|
|
|
|
Common Stock
|
|
Series A Preferred Stock
|
|
Additional
Paid-In Capital |
|
Accumulated
Deficit |
|
Total
Stockholders’ Equity (Deficit) |
||||||||||||||||
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balance, June 30, 2018
|
|
18,994,561
|
|
|
$
|
1,900
|
|
|
60,756
|
|
|
$
|
6
|
|
|
$
|
393,838,518
|
|
|
$
|
(410,459,463
|
)
|
|
$
|
(16,619,039
|
)
|
|
Interest and Dividend Expense paid with Common Stock
|
|
310,656
|
|
|
31
|
|
|
—
|
|
|
—
|
|
|
30,398
|
|
|
—
|
|
|
30,429
|
|
|||||
|
Conversion of St.George Note into Common Shares
|
|
3,142,332
|
|
|
314
|
|
|
—
|
|
|
—
|
|
|
102,186
|
|
|
—
|
|
|
102,500
|
|
|||||
|
Conversion of BayBridge Note into Common Shares
|
|
1,426,025
|
|
|
143
|
|
|
—
|
|
|
—
|
|
|
51,857
|
|
|
—
|
|
|
52,000
|
|
|||||
|
Conversion of Bellridge Note into Common Shares
|
|
3,660,498
|
|
|
366
|
|
|
—
|
|
|
—
|
|
|
137,134
|
|
|
—
|
|
|
137,500
|
|
|||||
|
Conversion of Note Payable into Common Shares
|
|
2,004,169
|
|
|
200
|
|
|
—
|
|
|
—
|
|
|
356,542
|
|
|
—
|
|
|
356,742
|
|
|||||
|
Loss on Extinguishment of Liabilities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
601,433
|
|
|
—
|
|
|
601,433
|
|
|||||
|
Stock based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,476
|
|
|
—
|
|
|
3,476
|
|
|||||
|
Adjustment for RSS
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,625
|
)
|
|
—
|
|
|
(2,625
|
)
|
|||||
|
Net Income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
383,494
|
|
|
383,494
|
|
|||||
|
Balance at September 30, 2018
|
|
29,538,241
|
|
|
$
|
2,954
|
|
|
60,756
|
|
|
$
|
6
|
|
|
$
|
395,118,919
|
|
|
$
|
(410,075,969
|
)
|
|
$
|
(14,954,090
|
)
|
|
|
|
Common Stock
|
|
Series A Preferred Stock
|
|
Additional
Paid-In Capital |
|
Accumulated
Deficit |
|
Total
Stockholders’ Equity (Deficit) |
||||||||||||||||
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balance, December 31, 2018
|
|
63,537,885
|
|
|
$
|
6,354
|
|
|
60,756
|
|
|
$
|
6
|
|
|
$
|
395,889,712
|
|
|
$
|
(418,531,968
|
)
|
|
$
|
(22,635,896
|
)
|
|
Interest and Dividend Expense paid with Common Stock
|
|
118,531,773
|
|
|
11,853
|
|
|
—
|
|
|
—
|
|
|
98,489
|
|
|
—
|
|
|
110,342
|
|
|||||
|
Conversion of St.George Note into Common Shares
|
|
602,361,830
|
|
|
60,236
|
|
|
—
|
|
|
—
|
|
|
194,834
|
|
|
—
|
|
|
255,070
|
|
|||||
|
Conversion of Global Ichiban Note into Common Shares
|
|
9,595,327
|
|
|
960
|
|
|
—
|
|
|
—
|
|
|
114,040
|
|
|
—
|
|
|
115,000
|
|
|||||
|
Conversion of BayBridge Note into Common Shares
|
|
790,692,046
|
|
|
79,069
|
|
|
—
|
|
|
—
|
|
|
185,931
|
|
|
—
|
|
|
265,000
|
|
|||||
|
Conversion of Bellridge Note into Common Shares
|
|
573,601,030
|
|
|
57,360
|
|
|
—
|
|
|
—
|
|
|
144,640
|
|
|
—
|
|
|
202,000
|
|
|||||
|
Conversion of Power Up Note into Common Shares
|
|
291,431,537
|
|
|
29,143
|
|
|
—
|
|
|
—
|
|
|
210,457
|
|
|
—
|
|
|
239,600
|
|
|||||
|
Conversion of GS Capital Note into Common Shares
|
|
327,651,670
|
|
|
32,765
|
|
|
—
|
|
|
—
|
|
|
39,953
|
|
|
—
|
|
|
72,718
|
|
|||||
|
Stock issued for fees
|
|
79,136,751
|
|
|
7,914
|
|
|
—
|
|
|
—
|
|
|
7,911
|
|
|
—
|
|
|
15,825
|
|
|||||
|
Conversion of Series A Preferred Stock into Common Stock
|
|
1
|
|
|
—
|
|
|
(12,656
|
)
|
|
(1
|
)
|
|
1
|
|
|
—
|
|
|
—
|
|
|||||
|
Loss on Extinguishment of Liabilities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
767,453
|
|
|
—
|
|
|
767,453
|
|
|||||
|
Stock based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
20,750
|
|
|
—
|
|
|
20,750
|
|
|||||
|
Net Loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,932,350
|
)
|
|
(1,932,350
|
)
|
|||||
|
Balance at September 30, 2019
|
|
2,856,539,850
|
|
|
$
|
285,654
|
|
|
48,100
|
|
|
$
|
5
|
|
|
$
|
397,674,171
|
|
|
$
|
(420,464,318
|
)
|
|
$
|
(22,504,488
|
)
|
|
|
|
Common Stock
|
|
Series A Preferred Stock
|
|
Additional
Paid-In Capital |
|
Accumulated
Deficit |
|
Total
Stockholders’ Equity (Deficit) |
||||||||||||||||
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balance, December 31, 2017
|
|
9,606,677
|
|
|
$
|
961
|
|
|
60,756
|
|
|
$
|
6
|
|
|
$
|
387,292,174
|
|
|
$
|
(402,495,476
|
)
|
|
$
|
(15,202,335
|
)
|
|
Interest and Dividend Expense paid with Common Stock
|
|
427,721
|
|
|
43
|
|
|
—
|
|
|
—
|
|
|
57,193
|
|
|
—
|
|
|
57,236
|
|
|||||
|
Conversion of St.George Note into Common Shares
|
|
5,412,610
|
|
|
541
|
|
|
—
|
|
|
—
|
|
|
493,559
|
|
|
—
|
|
|
494,100
|
|
|||||
|
Conversion of Global Ichiban Note into Common Shares
|
|
3,486,274
|
|
|
349
|
|
|
—
|
|
|
—
|
|
|
1,425,651
|
|
|
—
|
|
|
1,426,000
|
|
|||||
|
Conversion of BayBridge Note into Common Shares
|
|
4,237,792
|
|
|
424
|
|
|
—
|
|
|
—
|
|
|
564,576
|
|
|
—
|
|
|
565,000
|
|
|||||
|
Conversion of Bellridge Note into Common Shares
|
|
3,660,498
|
|
|
366
|
|
|
—
|
|
|
—
|
|
|
137,134
|
|
|
—
|
|
|
137,500
|
|
|||||
|
Conversion of Note Payable into Common Shares
|
|
2,004,169
|
|
|
200
|
|
|
—
|
|
|
—
|
|
|
356,542
|
|
|
—
|
|
|
356,742
|
|
|||||
|
Conversion of Series K Preferred Stock into Common Shares
|
|
702,500
|
|
|
70
|
|
|
—
|
|
|
—
|
|
|
2,809,930
|
|
|
—
|
|
|
2,810,000
|
|
|||||
|
Loss on Extinguishment of Liabilities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,959,963
|
|
|
—
|
|
|
1,959,963
|
|
|||||
|
Stock based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
24,822
|
|
|
—
|
|
|
24,822
|
|
|||||
|
Adjustment for RSS
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,625
|
)
|
|
—
|
|
|
(2,625
|
)
|
|||||
|
Net Loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,580,493
|
)
|
|
(7,580,493
|
)
|
|||||
|
Balance at September 30, 2018
|
|
29,538,241
|
|
|
$
|
2,954
|
|
|
60,756
|
|
|
$
|
6
|
|
|
$
|
395,118,919
|
|
|
$
|
(410,075,969
|
)
|
|
$
|
(14,954,090
|
)
|
|
|
|
For the Nine Months Ended
|
|
||||||
|
|
|
September 30,
|
|
||||||
|
|
|
2019
|
|
2018
|
|
||||
|
Operating Activities:
|
|
|
|
|
|
||||
|
Net Income (loss)
|
|
$
|
(1,932,350
|
)
|
|
$
|
(7,580,493
|
)
|
|
|
Adjustments to reconcile net (loss) to net cash used in operating activities:
|
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
185,163
|
|
|
289,324
|
|
|
||
|
Stock based compensation
|
|
20,750
|
|
|
24,822
|
|
|
||
|
Realized loss (gain) on sale of assets
|
|
(842,500
|
)
|
|
(14,000
|
)
|
|
||
|
Amortization of financing costs
|
|
24,639
|
|
|
21,750
|
|
|
||
|
Non-cash interest expense
|
|
2,023,031
|
|
|
935,190
|
|
|
||
|
Amortization of debt discount
|
|
3,675,795
|
|
|
3,690,823
|
|
|
||
|
Bad debt expense
|
|
(302
|
)
|
|
(8,868
|
)
|
|
||
|
Write off Enerplex Patents
|
|
—
|
|
|
59,153
|
|
|
||
|
Warranty reserve
|
|
(4,253
|
)
|
|
(9,702
|
)
|
|
||
|
Change in fair value of derivatives and loss on extinguishment of liabilities, net
|
|
(6,430,048
|
)
|
|
(2,599,870
|
)
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||||
|
Accounts receivable
|
|
143,059
|
|
|
(16,340
|
)
|
|
||
|
Inventories
|
|
(23,599
|
)
|
|
68,759
|
|
|
||
|
Prepaid expenses and other current assets
|
|
1,766
|
|
|
247,919
|
|
|
||
|
Accounts payable
|
|
(494,883
|
)
|
|
965,175
|
|
|
||
|
Related party payable
|
|
189,260
|
|
|
(2,827
|
)
|
|
||
|
Accrued interest
|
|
951,184
|
|
|
398,098
|
|
|
||
|
Accrued expenses
|
|
(51,880
|
)
|
|
487,690
|
|
|
||
|
Net cash used in operating activities
|
|
(2,565,168
|
)
|
|
(3,043,397
|
)
|
|
||
|
Investing Activities:
|
|
|
|
|
|
||||
|
Purchase of property, plant and equipment
|
|
(6,393
|
)
|
|
—
|
|
|
||
|
Proceeds from sale of assets
|
|
842,500
|
|
|
14,000
|
|
|
||
|
Patent activity costs
|
|
(9,361
|
)
|
|
(9,705
|
)
|
|
||
|
Net cash used in investing activities
|
|
826,746
|
|
|
4,295
|
|
|
||
|
Financing Activities:
|
|
|
|
|
|
||||
|
Proceeds from debt
|
|
1,762,268
|
|
|
3,102,500
|
|
|
||
|
Repayment of debt
|
|
(10,000
|
)
|
|
(89,686
|
)
|
|
||
|
Payment of debt financing costs
|
|
(7,500
|
)
|
|
(5,500
|
)
|
|
||
|
Net cash provided by financing activities
|
|
1,744,768
|
|
|
3,007,314
|
|
|
||
|
Net change in cash and cash equivalents
|
|
6,346
|
|
|
(31,788
|
)
|
|
||
|
Cash and cash equivalents at beginning of period
|
|
18,159
|
|
|
89,618
|
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
24,505
|
|
|
$
|
57,830
|
|
|
|
|
|
|
|
|
|
||||
|
Supplemental Cash Flow Information:
|
|
|
|
|
|
||||
|
Cash paid for interest
|
|
$
|
28,484
|
|
|
$
|
308,542
|
|
|
|
Cash paid for income taxes
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
Non-Cash Transactions:
|
|
|
|
|
|
||||
|
Non-cash conversions of preferred stock and convertible notes to equity
|
|
$
|
1,259,741
|
|
|
$
|
5,843,954
|
|
|
|
Non-cash financing costs
|
|
$
|
10,800
|
|
|
$
|
25,000
|
|
|
|
Accounts payable converted to notes payable
|
|
$
|
—
|
|
|
$
|
308,041
|
|
|
|
Interest converted to principal
|
|
$
|
171,152
|
|
|
$
|
140,355
|
|
|
|
Common shares issued for fees
|
|
$
|
15,825
|
|
|
$
|
—
|
|
|
|
Initial embedded derivative liabilities
|
|
$
|
3,781,186
|
|
|
$
|
2,736,724
|
|
|
|
Promissory notes exchanged for convertible notes
|
|
$
|
850,000
|
|
|
$
|
511,871
|
|
|
|
|
|
As of September 30,
|
|
As of December 31,
|
||||
|
|
|
2019
|
|
2018
|
||||
|
Building
|
|
$
|
5,828,960
|
|
|
$
|
5,828,960
|
|
|
Furniture, fixtures, computer hardware and computer software
|
|
489,421
|
|
|
489,421
|
|
||
|
Manufacturing machinery and equipment
|
|
26,593,588
|
|
|
30,302,806
|
|
||
|
Depreciable property, plant and equipment
|
|
32,911,969
|
|
|
36,621,187
|
|
||
|
Less: Accumulated depreciation and amortization
|
|
(28,632,301
|
)
|
|
(32,207,829
|
)
|
||
|
Net property, plant and equipment
|
|
$
|
4,279,668
|
|
|
$
|
4,413,358
|
|
|
|
|
As of September 30,
|
|
As of December 31,
|
||||
|
|
|
2019
|
|
2018
|
||||
|
Raw materials
|
|
$
|
684,390
|
|
|
$
|
660,791
|
|
|
Work in process
|
|
—
|
|
|
—
|
|
||
|
Finished goods
|
|
—
|
|
|
—
|
|
||
|
Total
|
|
$
|
684,390
|
|
|
$
|
660,791
|
|
|
|
|
Global Ichiban
|
|
St. George
|
|
Total
|
||||||
|
Secured Notes Principal Balance at December 31, 2017
|
|
$
|
4,557,227
|
|
|
$
|
—
|
|
|
$
|
4,557,227
|
|
|
New notes
|
|
1,935,000
|
|
|
1,315,000
|
|
|
3,250,000
|
|
|||
|
Note conversions
|
|
(1,426,000
|
)
|
|
—
|
|
|
(1,426,000
|
)
|
|||
|
Interest converted to principal
|
|
140,518
|
|
|
—
|
|
|
140,518
|
|
|||
|
Note assignments
|
|
(250,000
|
)
|
|
—
|
|
|
(250,000
|
)
|
|||
|
Secured Notes Principal Balance at December 31, 2018
|
|
4,956,745
|
|
|
1,315,000
|
|
|
6,271,745
|
|
|||
|
Less: remaining discount
|
|
(2,012,698
|
)
|
|
(811,667
|
)
|
|
(2,824,365
|
)
|
|||
|
Secured Notes, net of discount, at December 31, 2018
|
|
2,944,047
|
|
|
503,333
|
|
|
3,447,380
|
|
|||
|
New notes
|
|
—
|
|
|
845,000
|
|
|
845,000
|
|
|||
|
Note conversions
|
|
(115,000
|
)
|
|
—
|
|
|
(115,000
|
)
|
|||
|
Interest converted to principal
|
|
171,152
|
|
|
—
|
|
|
171,152
|
|
|||
|
Secured Notes Principal Balance at September 30, 2019
|
|
5,012,897
|
|
|
2,160,000
|
|
|
7,172,897
|
|
|||
|
Less: remaining discount
|
|
(995,249
|
)
|
|
(346,666
|
)
|
|
(1,341,915
|
)
|
|||
|
Secured Notes, net of discount, at September 30, 2019
|
|
$
|
4,017,648
|
|
|
$
|
1,813,334
|
|
|
$
|
5,830,982
|
|
|
Conversion Period
|
Principal Converted
|
Common Shares Issued
|
|||
|
Q1 2018
|
$
|
1,250,000
|
|
2,450,981
|
|
|
Q2 2018
|
$
|
176,000
|
|
1,035,295
|
|
|
Q1 2019
|
$
|
115,000
|
|
9,595,327
|
|
|
|
$
|
1,541,000
|
|
13,081,603
|
|
|
Period
|
Interest converted to Principal
|
||
|
Q1 2018
|
$
|
96,281
|
|
|
Q2 2018
|
$
|
44,237
|
|
|
Q1 2019
|
$
|
171,152
|
|
|
|
$
|
311,670
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
3,533,861
|
|
||
|
Change in fair value of derivative liability
|
(422,392
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
3,111,469
|
|
||
|
Closing Date
|
Closing Amount
|
Proceeds
|
||||
|
11/7/2018
|
$
|
260,000
|
|
$
|
200,000
|
|
|
11/19/2018
|
$
|
120,000
|
|
$
|
100,000
|
|
|
11/30/2018
|
$
|
120,000
|
|
$
|
100,000
|
|
|
12/7/2018
|
$
|
120,000
|
|
$
|
100,000
|
|
|
12/17/2018
|
$
|
120,000
|
|
$
|
100,000
|
|
|
1/3/2019
|
$
|
120,000
|
|
$
|
100,000
|
|
|
1/17/2019
|
$
|
120,000
|
|
$
|
100,000
|
|
|
1/30/2019
|
$
|
120,000
|
|
$
|
100,000
|
|
|
2/8/2019
|
$
|
120,000
|
|
$
|
100,000
|
|
|
Closing Date
|
Closing Amount
|
Proceeds
|
||||
|
3/15/2019
|
$
|
125,000
|
|
$
|
100,000
|
|
|
3/22/2019
|
$
|
120,000
|
|
$
|
100,000
|
|
|
4/4/2019
|
$
|
120,000
|
|
$
|
100,000
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
3,292,692
|
|
||||
|
Additional derivative liability on new notes
|
1,752,197
|
|
|||||
|
Change in fair value of derivative liability
|
(2,897,211
|
)
|
|||||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
2,147,678
|
|
||||
|
|
Investor 1
|
Investor 2
|
Total
|
||||||
|
Promissory Notes Principal Balance at December 31, 2017
|
$
|
494,437
|
|
$
|
200,000
|
|
$
|
694,437
|
|
|
New principal
|
—
|
|
850,000
|
|
850,000
|
|
|||
|
Notes exchanged
|
—
|
|
(200,000
|
)
|
(200,000
|
)
|
|||
|
Promissory Notes Principal Balance at December 31, 2018
|
494,437
|
|
850,000
|
|
1,344,437
|
|
|||
|
Less: remaining discount
|
—
|
|
(104,583
|
)
|
(104,583
|
)
|
|||
|
Promissory Notes, net of discount, at December 31, 2018
|
$
|
494,437
|
|
$
|
745,417
|
|
$
|
1,239,854
|
|
|
New principal
|
—
|
|
530,000
|
|
530,000
|
|
|||
|
Notes exchanged
|
—
|
|
(850,000
|
)
|
(850,000
|
)
|
|||
|
Promissory Notes Principal Balance at September 30, 2019
|
494,437
|
|
530,000
|
|
1,024,437
|
|
|||
|
Less: remaining discount
|
—
|
|
(70,000
|
)
|
(70,000
|
)
|
|||
|
Promissory Notes, net of discount, at September 30, 2019
|
$
|
494,437
|
|
$
|
460,000
|
|
$
|
954,437
|
|
|
|
Principal Balance 12/31/2017
|
New Notes
|
Notes assigned or exchanged
|
Notes converted
|
Principal Balance 12/31/2018
|
Less: Discount Balance
|
Net Principal Balance 12/31/18
|
||||||||||||||
|
October 2016 Notes
|
$
|
330,000
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
330,000
|
|
$
|
—
|
|
$
|
330,000
|
|
|
St. George Notes
|
1,705,833
|
|
—
|
|
—
|
|
(606,600
|
)
|
1,099,233
|
|
(96,177
|
)
|
1,003,056
|
|
|||||||
|
BayBridge Notes
|
—
|
|
—
|
|
270,000
|
|
(207,500
|
)
|
62,500
|
|
(62,100
|
)
|
400
|
|
|||||||
|
Bellridge Notes
|
—
|
|
150,000
|
|
550,000
|
|
(245,000
|
)
|
455,000
|
|
(123,360
|
)
|
331,640
|
|
|||||||
|
Power Up Notes
|
—
|
|
225,000
|
|
—
|
|
—
|
|
225,000
|
|
(110,621
|
)
|
114,379
|
|
|||||||
|
EMA Note
|
—
|
|
75,000
|
|
—
|
|
—
|
|
75,000
|
|
(1,753
|
)
|
73,247
|
|
|||||||
|
|
$
|
2,035,833
|
|
$
|
450,000
|
|
$
|
820,000
|
|
$
|
(1,059,100
|
)
|
$
|
2,246,733
|
|
$
|
(394,011
|
)
|
$
|
1,852,722
|
|
|
|
Principal Balance 12/31/2018
|
New Notes/Adjustments
|
Notes assigned or exchanged
|
Notes converted
|
Principal Balance 9/30/2019
|
Less: Discount Balance
|
Net Principal Balance 9/30/2019
|
||||||||||||||
|
October 2016 Notes
|
$
|
330,000
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
330,000
|
|
$
|
—
|
|
$
|
330,000
|
|
|
St. George Notes
|
1,099,233
|
|
(172,500
|
)
|
—
|
|
(255,070
|
)
|
671,663
|
|
—
|
|
671,663
|
|
|||||||
|
BayBridge Notes
|
62,500
|
|
—
|
|
1,160,000
|
|
(265,000
|
)
|
957,500
|
|
(658,333
|
)
|
299,167
|
|
|||||||
|
Bellridge Notes
|
455,000
|
|
—
|
|
—
|
|
(202,000
|
)
|
253,000
|
|
—
|
|
253,000
|
|
|||||||
|
Power Up Notes
|
225,000
|
|
149,500
|
|
—
|
|
(239,600
|
)
|
134,900
|
|
(61,263
|
)
|
73,637
|
|
|||||||
|
EMA Note
|
75,000
|
|
—
|
|
(75,000
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
|||||||
|
Widjaja Note
|
—
|
|
330,000
|
|
—
|
|
—
|
|
330,000
|
|
(54,909
|
)
|
275,091
|
|
|||||||
|
GS Capital Notes
|
—
|
|
178,568
|
|
75,000
|
|
(72,718
|
)
|
180,850
|
|
(79,167
|
)
|
101,683
|
|
|||||||
|
|
$
|
2,246,733
|
|
$
|
485,568
|
|
$
|
1,160,000
|
|
$
|
(1,034,388
|
)
|
$
|
2,857,913
|
|
$
|
(853,672
|
)
|
$
|
2,004,241
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
876,481
|
|
||
|
Additional derivative liability on new notes
|
—
|
|
|||
|
Change in fair value of derivative liability
|
(423,744
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
452,737
|
|
||
|
Conversion Period
|
Principal Converted
|
Common Shares Issued
|
|||
|
Q1 2018
|
$
|
75,000
|
|
187,500
|
|
|
Q2 2018
|
316,600
|
|
2,082,778
|
|
|
|
Q3 2018
|
102,500
|
|
3,142,333
|
|
|
|
Q4 2018
|
112,500
|
|
10,437,046
|
|
|
|
Q1 2019
|
106,750
|
|
58,503,244
|
|
|
|
Q2 2019
|
59,320
|
|
86,636,364
|
|
|
|
Q3 2019
|
89,000
|
|
457,222,222
|
|
|
|
|
$
|
861,670
|
|
618,211,487
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
1,060,000
|
|
||
|
Change in fair value of derivative liability
|
(975,258
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
84,742
|
|
||
|
Conversion Period
|
Principal Converted
|
Interest Converted
|
Common Shares Issued
|
|||||
|
Q4 2018
|
$
|
207,500
|
|
$
|
4,303
|
|
16,008,198
|
|
|
Q1 2019
|
90,500
|
|
3,278
|
|
47,400,806
|
|
||
|
Q2 2019
|
88,500
|
|
2,079
|
|
141,822,223
|
|
||
|
Q3 2019
|
86,000
|
|
2,261
|
|
616,247,346
|
|
||
|
|
$
|
472,500
|
|
$
|
11,921
|
|
821,478,573
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
113,846
|
|
||
|
Additional derivative liability on new notes
|
1,376,670
|
|
|||
|
Change in fair value of derivative liability
|
(423,893
|
)
|
|||
|
Liability extinguished
|
(152,301
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
914,322
|
|
||
|
Conversion Period
|
Principal Converted
|
Interest Converted
|
Common Shares Issued
|
|||||
|
Q3 2018
|
$
|
137,500
|
|
$
|
2,104
|
|
3,715,476
|
|
|
Q4 2018
|
107,500
|
|
4,000
|
|
7,554,399
|
|
||
|
Q1 2019
|
65,615
|
|
4,507
|
|
38,696,339
|
|
||
|
Q2 2019
|
47,385
|
|
3,875
|
|
68,142,087
|
|
||
|
Q3 2019
|
89,000
|
|
9,779
|
|
529,061,862
|
|
||
|
|
$
|
447,000
|
|
$
|
24,265
|
|
647,170,163
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
486,279
|
|
||
|
Liability extinguished
|
(43,521
|
)
|
|||
|
Change in fair value of derivative liability
|
(408,132
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
34,626
|
|
||
|
Conversion Period
|
Principal Converted
|
Interest Converted
|
Common Shares Issued
|
|||||
|
Q1 2019
|
$
|
182,500
|
|
$
|
7,300
|
|
95,014,902
|
|
|
Q2 2019
|
42,500
|
|
1,700
|
|
47,155,556
|
|
||
|
Q3 2019
|
14,600
|
|
—
|
|
155,824,176
|
|
||
|
|
$
|
239,600
|
|
$
|
9,000
|
|
297,994,634
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
511,137
|
|
||
|
Additional derivative liability on new notes
|
222,593
|
|
|||
|
Liability extinguishment
|
(511,137
|
)
|
|||
|
Change in fair value of derivative liability
|
(89,997
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
132,596
|
|
||
|
Derivative Liability Balance as of December 31, 2018
|
$
|
240,156
|
|
||
|
Liability assigned
|
(240,156
|
)
|
|||
|
Derivative Liability Balance as of June 30, 2019
|
$
|
—
|
|
||
|
Derivative Liability Balance as of December 31, 2018
|
$
|
—
|
|
||
|
Additional derivative liability on new notes
|
219,634
|
|
|||
|
Change in fair value of derivative liability
|
(77,774
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
141,860
|
|
||
|
Conversion Period
|
Principal Converted
|
Interest Converted
|
Common Shares Issued
|
||||||
|
Q2 2019
|
$
|
15,000
|
|
$
|
763
|
|
$
|
17,321,692
|
|
|
Q3 2019
|
$
|
57,718
|
|
$
|
4,284
|
|
$
|
335,425,736
|
|
|
|
$
|
72,718
|
|
$
|
5,047
|
|
$
|
352,747,428
|
|
|
Derivative Liability Balance as of December 31, 2018
|
$
|
—
|
|
||
|
Additional derivative liability on new notes
|
210,092
|
|
|||
|
Derivative liability assigned
|
240,156
|
|
|||
|
Change in fair value of derivative liability
|
(405,737
|
)
|
|||
|
Derivative Liability Balance as of September 30, 2019
|
$
|
44,511
|
|
||
|
Preferred Stock Series Designation
|
Shares Authorized
|
Shares Outstanding
|
||
|
Series A
|
750,000
|
|
48,100
|
|
|
Series B-1
|
2,000
|
|
—
|
|
|
Series B-2
|
1,000
|
|
—
|
|
|
Series C
|
1,000
|
|
—
|
|
|
Series D
|
3,000
|
|
—
|
|
|
Series D-1
|
2,500
|
|
—
|
|
|
Series E
|
2,800
|
|
—
|
|
|
Series F
|
7,000
|
|
—
|
|
|
Series G
|
2,000
|
|
—
|
|
|
Series H
|
2,500
|
|
—
|
|
|
Series I
|
1,000
|
|
—
|
|
|
Series J
|
1,350
|
|
—
|
|
|
Series J-1
|
1,000
|
|
—
|
|
|
Series K
|
20,000
|
|
—
|
|
|
|
|
For nine months ended September 30,
|
|
For nine months ended September 30,
|
||||
|
|
|
2019
|
|
2018
|
||||
|
Research and development
|
|
$
|
—
|
|
|
$
|
642
|
|
|
Selling, general and administrative
|
|
$
|
20,750
|
|
|
$
|
24,180
|
|
|
Total share-based compensation cost
|
|
$
|
20,750
|
|
|
$
|
24,822
|
|
|
|
|
Stock
Option Shares |
|
Weighted
Average Remaining Contractual Life in Years |
|
|
Outstanding at December 31, 2017
|
|
195
|
|
|
7.32
|
|
Granted
|
|
—
|
|
|
|
|
Exercised
|
|
—
|
|
|
|
|
Canceled
|
|
(85
|
)
|
|
|
|
Outstanding at December 31, 2018
|
|
110
|
|
|
5.18
|
|
Granted
|
|
—
|
|
|
|
|
Exercised
|
|
—
|
|
|
|
|
Canceled
|
|
(13
|
)
|
|
|
|
Outstanding at September 30, 2019
|
|
97
|
|
|
4.94
|
|
Exercisable at September 30, 2019
|
|
97
|
|
|
4.94
|
|
•
|
Our ability to generate customer acceptance of and demand for our products;
|
|
•
|
Successful ramping up of commercial production on the equipment installed;
|
|
•
|
Our products are successfully and timely certified for use in our target markets;
|
|
•
|
Successful operating of production tools to achieve the efficiencies, throughput and yield necessary to reach our cost targets;
|
|
•
|
The products we design are saleable at a price sufficient to generate profits;
|
|
•
|
Our ability to raise sufficient capital to enable us to reach a level of sales sufficient to achieve profitability on terms favorable to us;
|
|
•
|
Effective management of the planned ramp up of our domestic and international operations;
|
|
•
|
Our ability to successfully develop and maintain strategic relationships with key partners, including OEMs, system integrators, distributors, retailers and e-commerce companies, who deal directly with end users in our target markets;
|
|
•
|
Our ability to maintain the listing of our common stock on the OTCBB Market;
|
|
•
|
Our ability to implement remediation measures to address material weaknesses in internal control;
|
|
•
|
Our ability to achieve projected operational performance and cost metrics;
|
|
•
|
Our ability to enter into commercially viable licensing, joint venture, or other commercial arrangements; and
|
|
•
|
Availability of raw materials.
|
|
1.
|
Personnel and facility related expenses decreased
$39,246
, as compared to the same time period of
2018
. The decrease in personnel and facility related costs was primarily due to a reduction in headcount and the use of contractors.
|
|
2.
|
Materials and equipment related expenses, decreased
$16,761
, as compared to the same time period of
2018
. The decrease was due to a decrease in production of research and development products.
|
|
1.
|
Personnel and facility related costs increased
$38,270
during the
three months ended
September 30, 2019
, as compared to the the
three months ended
September 30, 2018
. The overall increase in personnel related costs was primarily due to the increased use of consultants and contractors for the the
three months ended
September 30, 2019
, as compared to the the
three months ended
September 30, 2018
, offset by a reduction in headcount during the same period.
|
|
2.
|
Marketing and related expenses decreased
$1,768
during the
three months ended
September 30, 2019
, as compared to the
three months ended
September 30, 2018
. The decrease in Marketing and related expenses is due to reduced marketing, advertising, and promotional activities during the the
three months ended
September 30, 2019
, compared to the same time period of 2018, which is the direct result of reducing our marketing budget to focus more on the development of our PV.
|
|
3.
|
Legal expenses decreased
$8,797
during the
three months ended
September 30, 2019
, as compared to the
three months ended
September 30, 2018
. The primary reasons for the decrease is due to decreased general legal expenses related to financing efforts as compared to the
three months ended
September 30, 2018
and decreases in legal expenses related to our patent activity as compared to the same period of
2018
.
|
|
4.
|
Public company expenses increased
$4,878
during the
three months ended
September 30, 2019
, as compared to the the
three months ended
September 30, 2018
. This increase is primarily due to accrued fees for the Company's board of directors, offset by the costs related to the reverse split which occurred during the
three months ended
September 30, 2018
.
|
|
5.
|
Bad debt expenses decreased approximately
$6,801
during the
three months ended
September 30, 2019
, as compared to the
three months ended
September 30, 2018
.
|
|
1.
|
During the
three months ended
September 30, 2019
, the Company disposed of certain manufacturing assets and recognized a gain of
$6,000
in Other income compared to a gain of
$13,144
for the
three months ended
September 30, 2018
, a reduction of
$7,144
.
|
|
2.
|
Interest expense increased approximately
$177,178
, as compared to the
three months ended
September 30, 2018
. The increase is primarily due to a increase of non-cash interest expense related to convertible debt and promissory notes.
|
|
3.
|
Gains and losses on change in fair value of derivatives and on extinguishment of liabilities, was a net gain of
$1,510,883
for the
three months ended
September 30, 2019
, as compared to a net gain of
$3,284,736
for the
three months ended
September 30, 2018
. The change of
$1,773,853
in this non-cash item is attributable to a net gain of
$1,518,008
on the change in fair value of our embedded derivative instruments during the
three months ended
September 30, 2019
, compared to
$3,858,483
in
2018
, offset by a net loss from extinguishment of liabilities of
$7,125
, related to conversions and redemptions of certain convertible notes and preferred stock, for the
three months ended
September 30, 2019
, as compared to a net loss of
$573,747
for
three months ended
September 30, 2018
.
|
|
|
Decrease (Increase) in Net Loss
For the Three Months Ended
September 30, 2019
Compared to the Three Months Ended
September 30, 2018
|
||
|
Revenues
|
$
|
306,372
|
|
|
Cost of Revenue
|
(74,271
|
)
|
|
|
Research, development and manufacturing operations
|
|
||
|
Materials and Equipment Related Expenses
|
16,761
|
|
|
|
Personnel and Facility Related Expenses
|
39,246
|
|
|
|
Selling, general and administrative expenses
|
|
||
|
Personnel, Administrative, and Facility Related Expenses
|
(38,270
|
)
|
|
|
Marketing Related Expenses
|
1,768
|
|
|
|
Legal Expenses
|
8,797
|
|
|
|
Public Company Costs
|
(4,878
|
)
|
|
|
Bad Debt Expense
|
6,801
|
|
|
|
Depreciation and Amortization Expense
|
32,950
|
|
|
|
Other Income/Expense
|
|
||
|
Interest Expense
|
(7,144
|
)
|
|
|
Other Income/Expense
|
(177,178
|
)
|
|
|
Non-Cash Change in Fair Value of Derivative Liabilities and Gain/Loss on Extinguishment of Liabilities, net
|
(1,773,853
|
)
|
|
|
Increase to Net Loss
|
$
|
(1,662,899
|
)
|
|
1.
|
Personnel and facility related expenses decreased
$1,237,527
, as compared to the same time period of
2018
. The decrease in personnel and facility related costs was primarily due to a reduction in headcount and the use of contractors.
|
|
2.
|
Materials and equipment related expenses, decreased
$73,494
, as compared to the same time period of
2018
. The decrease was due to a decrease in production of research and development products.
|
|
1.
|
Personnel and facility related costs decreased
$604,397
during the
nine months ended
September 30, 2019
, as compared to the the
nine months ended
September 30, 2018
. The overall decrease in personnel related costs was primarily due a lower headcount for the the
nine months ended
September 30, 2019
, as compared to the the
nine months ended
September 30, 2018
as well as the decreased use of consultants and contractors during the same period.
|
|
2.
|
Marketing and related expenses decreased
$22,145
during the
nine months ended
September 30, 2019
, as compared to the
nine months ended
September 30, 2018
. The decrease in Marketing and related expenses is due to reduced marketing, advertising, and promotional activities during the the
nine months ended
September 30, 2019
, compared to the same time period of
2018
, which is the direct result of reducing our marketing budget to focus more on the development of our PV.
|
|
3.
|
Legal expenses decreased
$165,483
during the
nine months ended
September 30, 2019
, as compared to the the
nine months ended
September 30, 2018
. The primary reasons for the decrease is due to decreased general legal expenses related to financing efforts as compared to the the
nine months ended
September 30, 2018
and decreases in legal expenses related to our patent activity as compared to the same period of
2018
.
|
|
4.
|
Public company expenses increased
$63,832
during the
nine months ended
September 30, 2019
, as compared to the the
nine months ended
September 30, 2018
. This increase is primarily due to accrued fees for the Company's board of directors, offset by the timing of the annual meeting in
2019
, and the costs of the reverse stock split in
2018
.
|
|
5.
|
Bad debt and settlement expenses increased
$30,120
during the
nine months ended
September 30, 2019
, as compared to the
nine months ended
September 30, 2018
. During
2018
we recorded payments and settlements against existing reserves. We did not have settlement expenses during
2019
.
|
|
1.
|
During the
nine months ended
September 30, 2019
, the Company disposed of certain manufacturing assets and recognized a gain of
$842,500
in Other income, compared to a gain of
$13,144
in
2018
, an increase of
$829,356
.
|
|
2.
|
Interest expense increased
$1,461,081
, as compared to the
nine months ended
September 30, 2018
. The increase is primarily due to an increase of non-cash interest expense related to convertible debt and promissory notes.
|
|
3.
|
Gains and losses on change in fair value of derivatives and on extinguishment of liabilities, was a net gain of
$6,430,048
for the
nine months ended
September 30, 2019
, as compared to a net gain of
$2,599,870
for the
nine months ended
September 30, 2018
. The change of
$3,830,178
in this non-cash item is attributable to a net gain of
$6,124,139
on the change in fair value of our embedded derivative instruments during the
nine months ended
September 30, 2019
, compared to a net gain
$4,532,147
in
2018
, and by an increase in the gain from extinguishment of liabilities of
$2,238,186
, related to conversions and redemptions of certain convertible notes and preferred stock, for the
nine months ended
September 30, 2019
, as compared to the the
nine months ended
September 30, 2018
.
|
|
|
Decrease (Increase) in Net Loss
For the Nine Months Ended
September 30, 2019
Compared to the Nine Months Ended
September 30, 2018
|
||
|
Revenues
|
$
|
115,651
|
|
|
Cost of Revenue
|
220,784
|
|
|
|
Research, development and manufacturing operations
|
|
||
|
Materials and Equipment Related Expenses
|
73,494
|
|
|
|
Personnel and Facility Related Expenses
|
1,237,527
|
|
|
|
Selling, general and administrative expenses
|
|
||
|
Personnel, Administrative, and Facility Related Expenses
|
604,397
|
|
|
|
Marketing Related Expenses
|
22,145
|
|
|
|
Legal Expenses
|
165,483
|
|
|
|
Public Company Costs
|
(63,832
|
)
|
|
|
Bad Debt Expense
|
(30,120
|
)
|
|
|
Depreciation and Amortization Expense
|
104,161
|
|
|
|
Other Income/Expense
|
|
||
|
Interest Expense
|
(1,461,081
|
)
|
|
|
Other Income/Expense
|
829,356
|
|
|
|
Non-Cash Change in Fair Value of Derivative Liabilities and (Gain)/Loss on Extinguishment of Liabilities, net
|
3,830,178
|
|
|
|
Decrease in Net Loss
|
$
|
5,648,143
|
|
|
•
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
|
•
|
provide reasonable assurance transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
|
|
•
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.
|
|
•
|
The Company was understaffed and did not have sufficiently trained resources with the technical expertise to ensure that all company transactions were accounted for in accordance with GAAP. This deficiency arose primarily from staff turnover and the inability of the Company to devote sufficient replacement resources in a timely manner, as a result of the Company's financial situation
|
|
•
|
Accounting for the Company's inventory and cost of revenue was lacking for the preparation of the
September 30, 2019
financial statements. Miscalculations in these areas could impact the Company's current assets, revenues, operating results, and cash flows.
|
|
•
|
The Company plans to engage a resource, either as internal staff or an external contractor, with the technical expertise to track and report on inventory transactions and cost of revenue calculations.
|
|
•
|
The Company will design and implement additional procedures in order to assure that the resource mentioned above and other audit/accounting personnel are more involved with the Company’s inventory activities and cost of revenue allocations to monitor and earlier identify accounting issues that may be raised by the Company’s ongoing activities.
|
|
Exhibit No.
|
|
Description
|
|
10.1
|
|
|
|
10.2
|
|
|
|
10.3
|
|
|
|
10.4
|
|
|
|
10.5
|
|
|
|
10.6
|
|
|
|
10.7
|
|
|
|
10.8
|
|
|
|
10.9
|
|
|
|
31.1*
|
|
|
|
31.2*
|
|
|
|
32.1*
|
|
|
|
32.2*
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
*
|
|
Filed herewith
|
|
|
ASCENT SOLAR TECHNOLOGIES, INC.
|
|
|
|
|
|
|
|
By:
|
/
S
/ VICTOR LEE
|
|
|
|
Lee Kong Hian (aka Victor Lee)
President and Chief Executive Officer
(Principal Executive Officer, Principal Financial Officer, Chief Accounting Officer, and Authorized Signatory)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|